Pro-Pharmaceuticals, Inc. Files $10 Million Shelf Registration

NEWTON, Mass.--(BUSINESS WIRE)--Pro-Pharmaceuticals, Inc. (Amex: PRW), a company "Advancing Drugs Through Glycoscience®", today announced it has filed a shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission (SEC).